New bed nets take on mosquito resistance in malaria battle
NCT ID NCT05796193
First seen Mar 24, 2026 · Last updated Jun 23, 2026 · Updated 11 times
Summary
This trial compares two new types of insecticide-treated bed nets against standard nets to see if they better prevent malaria in children aged 6 months to 10 years in central Côte d'Ivoire. About 1,650 people are taking part across multiple villages. The new nets contain either a chemical booster (PBO) or a second insecticide (chlorfenapyr) to overcome mosquito resistance. The study also looks at infection rates in all ages and mosquito numbers over three years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Pierre Richet
Bouaké, Côte d’Ivoire
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Insecticide-treated bed nets (Veeralin with alpha-cypermethrin and PBO, Interceptor G2 with alpha-cypermethrin and chlorfenapyr, or standard alpha-cypermethrin-only nets)
What this could lead to
If successful, these next-generation nets could provide better protection against malaria in areas where mosquitoes are resistant to standard insecticides, helping to keep malaria control on track.
What could go wrong
This is a field trial in one region of Côte d'Ivoire, and results may not apply everywhere. Mosquito resistance can change over time, and the nets' effectiveness may decrease with wear and tear.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.